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Disturbed host defense in peritoneal cavity during CAPD: Character-
ization of responsible factors in dwell fluid. In this study, the factors in
overnight dwell fluid (8 to 10 hr dwell) depressing granulocyte (GC)
NAD(P)H-oxidase dependent radical species production are character-
ized. At present, most studies have essentially focused on fresh, unspent
dialysate and on peritoneal macrophages. The response to Staphylococcus
aureus (Staph A) was dose-dependently depressed for both GC CO2
production (from 91.3 8.4 to 9.0 1.5 dpm/103 GC, P < 0.01) and
chemiluminescence (CL) (peak from 7.3 0.8 to 1.6 0.8 cps x 103/GC,
P < 0.01). Stimulation with formyl-methionine-leucine-phenylalanine
(f-MLP), phorbol myristic acid (PMA), Staphylococcus epidermidis (Staph
Epi), E. coli, latex and zymosan revealed a parallel depression, pointing to
an intrinsic metabolic defect, rather than failure of particle ingestion. The
addition of glucose to the normal cell medium to obtain the same
concentration as in the CAPD effluent (2.9 0.3 mg/dl) depressed
function but not to the same extent as the genuine PD effluent. Opsoniza-
tion of Staph A and E. coli induced a partial correction. No effect of pH
or osmolality was observed. HPLC fractionation of CAPD effluent on a
polarity based gradient revealed an elution of depressive factors in
hydrophobic fractions with a nadir in F7 and F12. Analysis of the elution
pattern of various uremic solutes revealed elution in F12 of p-cresol, a
solute with known inhibitoiy effect on GC function. These events may be
related to recent peritonitis (CL in response to Staph A 0.3 0.1 in
effluent of 6 patients with recent peritonitis versus 2.6 0.8 cps x 103/GC
in 12 patients without recent peritonitis (P < 0.01). We conclude that the
GC response is depressed in the presence of CAPD effluent due to excess
glucose, lack of opsonization, and uremic solutes of which p-cresol is one
of the responsible compounds.
During treatment with continuous ambulatory peritoneal dial-
ysis (CAPD), bacterial peritonitis remains the major source of
infectious morbidity, technical drop-out and mortality [1, 2]. The
continuous presence of dialysate in the peritoneal cavity is con-
sidered to be an unphysiologic factor playing a role in this
propensity for peritoneal infection [3—51.
Many studies have evaluated the effect of peritoneal dialysate
on host defense but they have focused on fresh, unspent dialysate
as it is introduced in the peritoneal cavity [6—81. For a host of
uremic retention solutes, a rapid exchange with serum contents
during peritoneal dwell time has been described, especially for low
molecular weight, water soluble compounds [9]. Hence, it is
conceivable that spent peritoneal fluid collected at the end of
dwell time may affect the immune defense in a different way
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compared to fresh dialysate. Studies evaluating the influence on
immune function of peritoneal dwell fluid are scant, and none of
those evaluated the relative importance of the individual factors
involved.
In addition, many studies concentrated on the effect of perito-
neal contents on functional capacity of macrophages or mono-
cytes [10—14]. Although macrophages are the major resident cells
in the sterile peritoneal cavity and are assumed to be the first line
of defense against invading microorganisms [15], polymorphonu-
clear granulocytes (GCs) become the predominant cell type in
peritonitis [31 The role of granulocytes in the effete immune
response of the peritoneum is at present less well defined.
A pivotal role in the inflammatory response against infection is
played by the destruction of ingested bacteria by oxygen radical
species [16—18]. This mechanism involves the breakdown of
glucose through the hexose-monophosphate shunt (HMS) path-
way; the energy delivered by this process is used in the activation
of the NAD(P)H-oxidase enzyme system for the production of
reactive oxygen species (ROS), including superoxide anions,
hypochlorite, hydrogen peroxide, hydroxyl radicals and other
compounds, that have a destructive impact on bacteria and
tissues.
In recent studies in end-stage renal disease, a decrease was
demonstrated in the metabolic breakdown of glucose by the
hexose monophosphate shunt (HMS), associated with the respi-
ratory burst in response to phagocytosis of various stimuli such as
latex, zymosan and Staphylococcus aureus (Staph A) [19—21].
The present study evaluates whether peritoneal dwell fluid
affects indices of the activity of NAD(P)H-oxidase during the
respiratory burst of peritoneal phagocytic cells with an emphasis
on the GCs following challenge with various stimuli. In addition,
the relative importance of various factors that reportedly may
affect immune defense, such as the presence of glucose and other
osmoles [61, pH changes [22], and lack of opsonins [11, 23] was
evaluated separately.
Methods
Sample collections
Blood samples for isolation of GCs were collected from subjects
with normal renal function [5Cr < 1.3 mg/tOO ml (114.9 amol/
liter), CCr> 80 mI/mini. Effluent peritoneal dialysate for isolation
of peritoneal macrophages and for evaluation of the effect on
phagocytic function was collected after an overnight dwell (8 to 10
hr) from equilibrated patients, on CAPD for at least three
months, and with Sr > 8 mg/100 ml (707.2 i.tmol/liter). Except for
the study of the potential relation with recent peritonitis, and for
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the study of the effect of infected effluent, dialysate effluent from
patients with peritonitis within three months was excluded, as well
as from patients treated within three months before study with
antibiotics, corticosteroids or immunosuppressive medications.
Peritonitis was documented in spent dialysate by positive bacterial
cultures and/or leukocytosis > 100 cells/jil. Only dwell fluid from
instilled dialysate with a glucose content of 1.36% (Dianeal' 137,
Baxter, Lessines, Belgium; composition in mmol/liter: Na 132;
Ca2 1.75; Mg2 0.75; CL 102; lactate 35), or from Ringer's
lactate solution (Na 130; K 4; Ca2 1.35; CL 109; lactate 27.7)
was evaluated. All spent dialysates were studied immediately after
their withdrawal from the peritoneal cavity.
Methods
Granulocyte isolation. Isolated granulooytes were obtained,
starting from heparinized whole blood samples, as previously
described [24, 25]. Cells were finally suspended, either in normal
autologous plasma or in CAPD effluent [± 5 x 106 cells/ml
(counted in an automated cell counter)]. Differential cell counts
after May-Grunwald staining revealed > 90% GCs. GC viability,
controlled after the isolation procedure by Trypan blue exclusion,
was positive in more than 95% of the cells.
Isolation of peritoneal macrophages. Peritoneal macrophages
were collected from CAPD effluent (overnight dwell). After
centrifugation (600 g X 20 mm at 4°C), and decantation of
supernatant, cells were resuspended in Hank's buffer. Macro-
phages were then further separated by adding carefully to 2 mL of
the cell suspension 3 ml NicoPrepTM (Nycomed, Oslo, Norway;
density 1.063 g/ml). After centrifugation (600 g x 20 mm), the
macrophage layer was decanted, and cells were resuspended
either in a pool of normal plasma or in CAPD effluent at a
concentration of 5 X 10 cells/mm3. Viability was checked as
above. Cell identification by FACScan (light scattering analysis;
Becton & Dickinson, San Jose, CA, USA), revealed the presence
of> 90% macrophages.
Granulocyte and macrophage glucose-1-'4C consumption. The
principle of the assay has been described in detail [19]. In brief,
HMS activity was evaluated by measurirg 14C02 generated from
the metabolism of glucose-1-14C by the HMS pathway, with and
without incubation with latex, zymosan, Staph A, Staphylococcus
epidermidis (Staph Epi) or E. coli ,ticles as phagocytic challeng-
ers, and/or phorbol myristic acid (PMA) and formyl-methionine-
leucine-phenylalanine (f-MLP) as humoral stimuli. The principle
of this assay is based on the HMS glycolytic pathway in granulo-
cytes, which delivers energy to NAD(P)H-oxidase in the genera-
tion of free radical species. The rise in CO2 production (h C02)
after addition of challenging agents is reported.
Latex, zymosan, Staph A, f-MLP and PMA suspensions were
prepared as previously described [19, 25, 26]. E. coli and Staph Epi
were obtained after culture and repeated washing, in suspensions
containing approximately 5 X 108 bacteria/mi.
For some experiments, bacteria were opsonized by suspending
Staph A or E. coli after centrifugation and withdrawal of the
supernatant, in equivalent quantities of a pool of serum from
healthy donors. After 30 minutes at 37°C in a shaking incubator,
the particles were washed twice in isotonic saline, before their
addition to GC samples.
In preliminary studies, interference on glucose-1-14C consump-
tion of shifts in sodium, potassium, calcium and phosphorus
within physiologic ranges were excluded [19].
Chemiluminescence production. GC samples were prepared as
described above. For each evaluation, either 100 d of GHBSS
(for registration of resting state activity) or 100 jil of stimulus
(Staph A) suspension were added to 50 jid of cell suspension, in a
polystyrene inserting tube, together with 500 1.d of a luminol test
solution (56 jsmol/liter). The luminol was kept in a stock solution
at 56 mmol/liter, and was further diluted 1/1000 immediately
before the experiment. The test tube was immediately processed
into a luminescence analyzer (Lumicon, Hamilton, Switzerland).
The photon counting value, which is indicated arbitrarily in
relative light units (RLU), was registered with a counting interval
set at 30 seconds and a total recycling time of 30 minutes.
Computed recording allowed the registration of the following
values: number of counts, calculated integral of counts over the
total cycling time, and peak value.
HPLC-procedure. Overnight CAPD effluent was fractionated by
high performance liquid chromatography, in order to define the
elution characteristics of so lutes with a potential inhibitory capac-
ity on GC-function, according to a previously described procedure
t25, 27, 28]. From each CAPD effluent under study, 3 ml were
submitted to HPLC-fractionation after ultrafiltration through an
Amicon CentrifreeTM filter (cut-off 3,000 Daltons) (Amicon Di-
vision, WR Grace & Company, Danvers, MA, USA). The CAPD
effluent was fractionated with polarity-based semipreparative
HPLC. Separation occurred in 15 fractions, each fraction being
collected over four minutes, using an automated fraction collector
FRAC-300 (Pharmacia, Uppsala, Sweden).
Individual peaks were recorded by simultaneous registration of
UV-absorption (254 nm) (Uvicord SIl 2238; Pharmacia) and
fluorescence-emission (excitation/emission 280/340 nm) (Fluores-
cence HPLC monitor RF-530; Shimadzu, Kyoto, Japan) in series.
Study design
Effect of various concentrations of CAPD effluent. Normal gran-
ulocytes were either suspended in their autologous plasma, in an
equivoluminous quantity of CAPD effluent, or in a solution
containing 30% CAPD effluent/70% autologous plasma or 70%
CAPD effluent/30% autologous plasma. The production of CO2
and of chemiluminescence in response to Staph A was evaluated
(N = 10).
In a separate analysis, the effect of CAPD effluent on the
C02-production of normal granulocytes challenged by latex,
zymosan, Staph A, PMA and f-MLP was evaluated (control vs.
100% effluent, N = 10; dose-response, N = 3). Finally, the
response of normal GC in autologous plasma or in 100% CAPD
effluent towards Staph Epi and E. coli was evaluated (N = 8).
The response of peritoneal macrophages, either suspended in a
pool of normal plasma or in 100% CAPD effluent (response to
Staph A, N = 6), was also evaluated.
Evaluation of the role of glucose. Since most of the samples
under study contained a concentration of glucose, in excess of
normal blood glucose levels, glucose concentration of the CAPD
effluent was measured by standard methods, before the experi-
mental evaluation of GC function. Normal GCs were then
suspended in autoiogous plasma, in CAPD effluent (100%) or in
autologous plasma containing the same quantity of glucose as the
corresponding CAPD effluent (N = 10), and the CO2 production
and the chemiluminescence response to Staph A were studied.
Evaluation of the role of lack of opsonins. In view of the current
hypothesis that CAPD effluent contains insufficient amounts of
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opsonins [11], and that this may have a negative effect on the
bacterial ingestion and subsequent destructive response on bac-
teria [23], Staph A or E. coli were either added as such, or in
identical concentrations after opsonization (N = 10).
Effect of pH. The effect of shifts in cell medium pH was
evaluated by adding to GC's uremic plasma titrated with either
HC1 1 or NaOH I mol/liter or untreated uremic plasma, to obtain
a paired comparison between pH 6.0, 8.5 and 7.4 (N = 3).
Effect of ultrafiltration (cut-off 3,000 Daltons). To evaluate the
range of molecular weight of potential inhibitors of GC function,
CAPD effluent was either added to GCs or after ultrafiltration
through a polysulfone ultrafiltration membrane (Amicon Centri-
freeTM, WR Grace & Company). The response to latex, zymosan
and Staph A was evaluated (CO2 production; N = 3).
Effect of osmolality. To evaluate the effect of osmolality in the
range observed in CAPD effluents (324 to 344 mOsm/liter), 0.100
and 0.200 ml mannitol 20% were added to normal plasma, and
GC functional response was evaluated and compared to the
response of GCs suspended in normal plasma alone (N = 5).
Evaluation of CAPD effluent with glucose concentrations compa-
rable to normal plasma glucose. To exclude a bias in the results of
CO2 production due to the competitive presence of excess glucose
in CAPD effluent, CAPD effluents containing glucose at concen-
trations comparable to normal plasma glucoses were collected.
C02-production in response to Staph A was evaluated after
suspension of normal GCs in autologous plasma or CAPD
effluent (N = 7).
Study of the effect of dialysate containing Ringer-lactate. The use
of dialysate containing no glucose as an osmotic agent was also
inspired by an attempt to obtain effluent glucose concentrations
that were as low as possible, that is, comparable to normal blood
levels. For the rest, the same protocol was used as for the glucose
containing dialysate, that is, the collection of an overnight dwell
(N=5).
Study of HPLC-fractions. This part of the study appreciates the
characteristics of the solutes in CAPD effluent that affect GC
functional capacity. Seven CAPD effluents were collected after an
overnight dwell. Fifteen HPLC-fractions were obtained as de-
scribed above, freeze dried, and added to GCs from healthy
donors suspended in their normal autologous plasma (1 ml). The
reaction towards Staph A was evaluated. As a control, GCs were
suspended in their autologous plasma without the addition of
lyophilized HPLC-fractions. Note that both the control and the
experimental white blood cells were suspended in autologous
plasma.
A standard solution containing six uremic solutes (urea, creat-
me, p-cresol, phenol, hippuric acid and indoxyl sulfate) was
submitted to the same procedure.
P-cresol concentrations. In view of the suggested inhibitory role
of p-cresol, we evaluated p-cresol concentration in serum and PD
effluent of patients subjected to CAPD (N = 9). P-cresol was
measured by a modification of the methods described by Niwa et
al [29] and by Brega et al [30]. In brief, after displacement of
p-cresol from eventual serum proteins by acidification and satu-
ration with NaC1 (100 mg in 0.1 ml), p-cresol was extracted with 4
ml isopropyl ether. The isopropyl ether was evaporated after
addition of 0.1 ml NaOH. The dry residue was redissolved and
analyzed by HPLC on a C18 column (same procedure as in HPLC
procedure, above), with a methanol gradient from 40 to 75% in 13
minutes at a flow rate of 1 ml/min. P-cresol was detected by
fluorescence (extinction 284 nm, emission 310 nm). Concentra-
tions were measured on genuine untreated samples (to estimate
total concentration) and on samples submitted to ultrafiltration
through a polysulfone ultrafiltration membrane (Amicon Centri-
freeTM), to obtain free, non-protein bound concentration, and %
protein binding was calculated.
Potential relation with recent peritonitis. CAPD effluents were
collected from 6 patients having developed peritonitis in the six
months preceding the collection, and in 12 patients having
developed no peritonitis. The peritonitis episodes were due to
Staph A in 5 patients and to Staph Epi in 1 patient. The peritonitis
episode needed to be cured for at least one month, as proven by
negative cultures and leukocyte counts < 100 cells4d. Both
chemiluminescence and CO2 production were measured.
Comparison of infected and non-infected peritoneal effluent. To
evaluate possible changes in responsiveness in the presence of
peritonitis, isolated normal granulocytes were suspended in pen-
toneal effluent, obtained from 9 patients with active peritonitis
(first day of infection, before start of antibiotic treatment), in a
paired comparison with cells suspended in effluent obtained from
patients without peritonitis, and with cells in autologous plasma.
Glucose concentrations in the fluid samples were normalized by
adding the appropriate amount of glucose to the samples with the
lowest concentration. The response to zymosan was evaluated.
Statistical analyses
Results are expressed as means standard error of mean
(means SEM). Data are compared by variance analysis and if
statistical significance is reached by paired or unpaired Wilcoxon's
test where appropriate.
Results
Effect of various concentrations of CAPD effluent
The glucose, Na, K, BUN and creatinine concentrations of
the normal plasma samples for suspending the GCs were respec-
tively: 1.05 0.04 mg/mI, 141.0 0.3 mo1/ml, 4.2 0.1 tmol/ml,
0.20 0.01 mg/mi and 11.6 0.5 tg/ml. The respective concen-
trations in CAPD effluent were: 2.91 0.31 mg/ml, 135.0 1.1
.tmol/ml, 3.3 0.3 iimol/ml, 0.51 0.05 mg/mI and 57.7 0.9
4LLg/ml.
The effect of various concentrations of CAPD effluent is
illustrated in Figure 1. Either CO2-production (left) or chemilu-
minescence response (integrated counts -middle or peak value -
right) are illustrated. For each of the parameters, a decline in
functional capacity was observed with increasing quantities of
CAPD effluent.
The response to latex, zymosan, Staph A, PMA and f-MLP of
normal GC, suspended in their autologous plasma or in 100%
CAPD effluent (Fig. 2), showed a substantial decline in response
capacity for each stimulus, including the humoral stimuli phorbol
myristic acid (PMA) and formyl-methionine-leucine-phenylala-
nine (f-MLP). In Figure 3, the dose response evaluation (CO2
production) with 0, 30, 70 and 100% CAPD effluent and these five
stimuli is illustrated. If the changes are expressed as a percentage
versus normal plasma (Fig. 3, insert), there is a marked parallel
decline of the response for all five stimuli. CO2 production in
response to Staph Epi andE. coli decreased from 45.1 4.2 to 2.3
0.5 (P < 0.01) and from 47.8 3.0 to 3.2 0.7 dpm/103 GC
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Fig. I. CO2 production (left) and chemiluminescence [Counts (middle) and peak (right)] in response to Staph A of normal grunulocytes suspended in their
autologous plasma (A), in autologous plasma with 30 and 70% CAPD effluent (B and C), or in 100% CAPD effluent (D). There is a progressive decline
in response with increasing quantities of CAPD-fluid. *p < 0.05, < 0.01 versus normal plasma.
production and of chemiluminescence in the presence of this
excess glucose was observed (P < 0.05), but the decrease in the
presence of genuine CAPD effluent containing the same amount
of glucose was markedly more pronounced (P < 0.01). These data
indicate that the alterations in GC response in the presence of
CAPD effluent should be attributed to more than the influence of
excess glucose alone. Depression of the response is a more
important factor when evaluating CO2 production, compared to
chemiluminescence, suggesting that the major effect of glucose on
CO2 production can be attributed to competition between cold
and radioactive glucose as a substrate for glucose breakdown in
the respiratory burst.
Fig. 2. Response in CO2 production to latex, zymosan, Staph A, PMA or
f-MLP, of normal granulocytes in the presence of normal plasma (, each
time on the left), or 100% CAPD effluent (Lii, each time on the right). *p <
0.05, P < 0.01 versus normal plasma. The parallel between the response
to particles and to non-particles suggests that there is no pathophysiologic
role for a disturbance in phagocytosis (particle ingestion), but rather for
failure of the metabolic response axis.
(P < 0.01), respectively, normal plasma versus 100% CAPD
effluent.
Analysis was also performed on peritoneal macrophages, either
suspended in a pool of normal plasma or in 100% CAPD effluent,
showing a depression of the CO2 response versus Staph A (from
12.9 4.2 to 4.6 1.6 dpm/103 GC, P < 0.05) and of chemilu-
minescence in the presence of CAPD effluent (peak value from
1.9 0.6 to 0.8 0.5 cps x 103/GC, P < 0.01).
Evaluation of the role of glucose
As the CAPD effluent evaluated above contained 2.91 0.31
mg/mi glucose (range 1.22 to 6.54 mg/mI), we then evaluated
whether this excess glucose altered granulocyte functional capac-
ity. Glucose was added to normal plasma at the same concentra-
tion as in CAPD effluent (Fig. 4). A marked decline in CO2
Evaluation of the role of lack of opsonins
To evaluate the potential implications of opsonin depletion, the
CO2 and chemiluminescence response versus opsonized Staph A
was compared to the response to the currently used, non-
opsonized Staph A in the presence of 100% CAPD effluent (Fig.
4). Although opsonization caused a significant increase in re-
sponse for both CO2-production and chemiluminescence (P <
0.05 compared to non-opsonization), no correction to normal
values could be observed, suggesting that an opsonization defect
was only partly responsible for the effete response in the presence
of CAPD effluent, and that other factors were equally playing a
role. Improvement in response to E. coli after opsonization to a
value of 9.5 2.1 dpm/103 GC (P < 0.05 vs. non-opsonized) was
observed. Chemiluminescence data paralleled these results.
Effect of pH
The pH of the CAPD effluents under evaluation was 7.37
0.03 (range 7.2 to 7.5). Shift of pH, largely outside these bound-
aries (6.0 to 8.5), induced no significant differences in the GC
response (CO2 production in response to Staph A at pH 7.4 in
CAPD effluent, 26.2 9.3; at pH 6.0, 30.9 10.7; at pH 8.5, 23.2
2.2 dpm/103 GC; P = NS).
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Fig. 3. Increase in CO2 production in presence
of 0, 30, 70 and 100% CAPD effluent. Symbols
are the stimuli (from above to below in normal
plasma): (—) zymosan; (. . . .) PMA; (
Staph A; (—— — —) latex; (——) f-MLP.
Insert. Identical data expressed as a percentage
versus normal. There is a remarkable parallel
between all data (for comments see Fig. 2).
Fig. 4. Effect of glucose and of opsonization on C02-production (left) and chemiluminescence [counts (middle) and peak (right)] in response to Staph .4.
A. GC in autologous plasma. B. Glucose added to normal autologous plasma at the same concentration as in CAPD effluent (2.91 0.31 mg/ml). C.
100% CAPD effluent with non-opsonized Staph A. D. 100% CAPD effluent after opsonization of the same staphylococcal strain. < 0.05, < 0.01
versus normal plasma (A); P < 0.05, °°P < 0.01 versus non-opsonized Staph A in CAPD effluent (C).
Effect of ultrafiltration
Ultrafiltration of CAPD effluent over a 3,000 Dalton filter
revealed no difference in the GC response (response to latex
remaining at 2 1 dpm/103 GC before and after UF; response to
zymosan from 1.5 0.7 to 1.0 0.8 dpm/103 GC; response to
Staph A from 5.3 2.5 to 3.5 2.3 dpm/103 GC in the presence
of 100% effluent). These data suggest that the suppressive agents
are at least in part low molecular weight compounds.
Effect of osmolality
Pursuing osmolalities compared to those in the CAPD effluent
(324 to 344 mOsm/liter) by adding marinitol to normal plasma had
no effect on the GC response.
Evaluation of CAPD effluent with glucose concentrations
comparable to normal plasma glucose
In this part of the study, normal PNMLs were suspended, either
in their normal autologous plasma, or in 100% CAPD effluent,
which before a glucose concentration had been determined in
comparable to that of the normal plasma samples (1.2 mg/ml for
CAPD vs. 1.1 mglml for plasma). Under these conditions, C02-
production in response to Staph A was 114.8 12.5 in normal
plasma and 34.4 2.2 dpm/103 GC in CAPD effluent (P < 0.01;
Fig. 5).
Study of the effect of dialysate containing Ringer-lactate
The CO2 production in plasma compared to effluent from
dialysate containing no glucose as an osmotic agent showed a
CAPD 30% CAPD 70% CAPD 100%
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decrease in the response to latex from 18.6 6.5 to 4.7 1.0
dpm/103 GC and to zymosan from 68.3 1.0 to 11.2 0.8 (P <
0.05) (glucose concentration in effluent was 0.9 0.1 mg/mI). A
similar decrease was also found in one single experiment for Staph
A (from 37.2 to 14.7 dpm/103 GC).
Study of HPLC fractions
The effect of 15 different HPLC fractions of effluent (gradient
formiate to methanol) on normal GCs in autologous plasma was
compared to control (without the addition of fractions). A de-
pression in granulocytic response was observed in hydrophilic
fraction 2 (elution time 4 to 8 mm) and in the more hydrophobic
fractions 7 and 11 to 13 (elution times 24 to 28, and 40 to 52 mm)
(Fig. 6), with a nadir in fractions 7 and 12.
Evaluation of the standard solution containing six uremic toxins
revealed the elution of only p-cresol in one of the fractions with a
significant inhibition on the phagocytic capacity (F12).
P-cresol concentrations
P-cresol was significantly higher in the serum of CAPD-patients
compared to their PD effluent (0.67 0.21 vs. 0.09 0.03 mg/lOU
ml; P < 0.01). Nevertheless, the free unbound concentrations
were similar (0.06 0.02 vs. 0.05 0.03 mg/100 ml).
Potential relationship with recent peritonitis
Glucose concentrations in the eluents were 326 47 mg/dl for
patients without peritonitis versus 245 33 mg/dl for patients
with recent peritonitis (P> 0.05). As illustrated in Figure 7, both
chemiluminescence production of non-opsonized and opsonized
Staph A was significantly higher in patients who developed no
peritonitis in the six months before their evaluation. Chemilumi-
nescence was also significantly higher for opsonized Staph A,
compared to non-opsonized Staph A, in the patients subsequently
developing infection. No significant differences were seen in CO2
production, unless it was between opsonized and non-opsonized
particles.
Comparison of infected and non-infected PD effluent
As expected, CO2 production was lower when GCs were
suspended in non-infected PD effluent, compared to normal
plasma supplemented with glucose (29.5 6.6 vs. 0.5 0.4
dpm/103 GC; P < 0.01). Although the response was slightly higher
in infected PD effluent (2.9 0.9 dpm/103 GC; P < 0.01 vs.
non-infected effluent), it still remained 10 times below the
response in control conditions (P < 0.01 vs. autologous plasma).
Similar changes were observed for chemiluminescence analysis.
Discussion
The principal conclusion of this study is that peritoneal effluent,
after an overnight dwell, contains various factors that depress
granulocytic as well as monocytic functional capacity to produce
free radical species in response to phagocytosis. This is attributed
to excess glucose, a lack of opsonins, and uremic retention solutes.
No effect could be attributed to pH or osmolality.
Earlier studies have especially demonstrated a reduced respon-
siveness of peritoneal macrophages [10—14, 31]. However, gran-
ulocytes are the most frequent cell type providing an immune
response, once infection is installed [15]. In the present study, a
depressive effect of peritoneal effluent on normal blood granulo-
cyte function has been demonstrated. The possibility should be
considered that this effect could be even more deleterious in
peritoneal granulocytes of CAPD-patients, in view of the depres-
sion of phagocyte functional capacity currently observed in uremia
[19].
Several studies indicate that fresh unspent peritoneal dialysate,
as it is instilled in the peritoneal cavity, suppresses leukocyte
function. The presence of lactate and the acidic pH are considered
the main responsible factors for this suppression [6, 22, 32].
However, both lactate and bicarbonate are water soluble low
molecular weight compounds that are exchanged for virtually
100% across the peritoneal barrier before the end of the 8 to 10
hour dwell time respected in the current study [33-35]. Therefore,
it is conceivable that the presently registered decrease in GC
response in the presence of CAPD effluent is related to other
factors.
Phagocytosis (particle ingestion) as such has been demon-
strated to be unaffected by peritoneal effluent [36, 37]. Although
phagocytosis is not directly addressed in the current study, the
parallel decrease in response versus particle as well as humoral
stimuli (Figs. 2 and 3), points away from an alteration of phago-
cytosis per se (Fig. 8). Also, in other conditions of the uremic
status, effete phagocytosis appears to play a relatively unimportant
role [38]. In contrast, our data point in the direction of a
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Fig. 5. CO2 production in response to Staph A in normal plasma (left)
versus CAPD effluent (right) where the glucose concentration was similar to
normal plasma (1.2 vs. 1.1 mg/mI), values in CAPD effluent being lower (P <
0.01).
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Fig. 6. CO2 production (s—.) and
chemiluminescence (- - - A- - -) in response to
Staph A for GCs suspended in their autologous
normal plasma (NP) or after the addition of
lyophilizate of HPLC-fractions to this normal
plasma. A significant inhibition is observed for
fractions 2, 7, and 11 to 13. 0p < 0.05, 00P <
0.01 versus NP.
Fig. 7. Chemiluminescence (A) and C02-production (B) in response to
Staph A after suspension in effluent of patients having or having not developed
peritonitis in the preceding six months. Non-opsonized (open bars) and
opsonized (hatched bars) Staph A. op < 0.05, ** P < 0.01 versus patients
with peritonitis. °P < 0.05 versus non-opsonized Staph A.
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depression of the metabolic axis consisting of hexose monophos-
phate shunt, NAD(P)H-oxidase and protein kinase C (Fig. 8),
since even the response to the direct PKC activator PMA is
depressed. It should be remembered that if normal phagocytosis is
followed by a deficient respiratory burst, as is suggested by the
present results, infective bacteria may remain alive in unrespon-
sive leukocytes, resulting in a relapse of infectious disease during
or after antibiotic treatment [23, 39]. Improvement of the meta-
bolic defect by enhancers of NAD(P)H-oxidase or other aspects
of immune response, such as the third generation cephalosporin
cefodizime or interferon [40—42], may be a potential method to
correct for this functional failure.
Excess glucose in peritoneal effluent is one of the factors
affecting the GC response in this study (Fig. 4). Glucose has been
demonstrated before, in CAPD as well as in other settings, to
affect several aspects of the immune response, such as the release
of leukotriene B4, tumor necrosis factor and interleukin-6, lectin
receptor regulation, antigen presentation, particle ingestion and
killing of Candida [6, 43, 44].
Opsonization of particles induced a more effective GC response
(Figs. 4 and 7). Hence, the lack of opsonins currently described in
the peritoneal effluent [3, 11, 45] conforms with the hypothesis
held by Keane and Peterson [3], in part responsible for the effete
immune response in the presence of this peritoneal effluent.
However, neither presence of glucose levels in peritoneal
effluent comparable to normal glycemic levels (Fig. 5) nor opso-
nization of particles (Fig. 4) restores the granulocyte response to
normal, suggesting that at least a third factor is at play. The
inhibition in the presence of lyophilisate of HPLC-eluates of
effluent suggests that these are uremic retention products that are
removed peritoneally. The present approach allows some indica-
tions about the nature of the responsible retention solutes.
Inhibition of phagocytosis is seen in the presence of lyophilisate of
at least two different elution zones on C18 reverse-phase HPLC.
The latter method allows the separation of small molecular
compounds (< 3,000 Daltons) according to their polarity, with
hydrosoluble substances eluting early after the start of HPLC [27,
28]. Data recently presented by Haag-Weber, Mai and HOrl also
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Fig. 8. Metabolic pathways involved in the
activation of N.4D(P)H-oxidase in respiratoty
burst. Abbreviations are: f-MLP,
formyl-methionine-leucine-phenylalanine; PMA,
phorbol myristic acid; PKC, protein kinase C;
NADPH-OX, NAD(P)H-oxidase; HMS, hexose
monophosphate shunt. Stimulation of PKC
after phagocytosis (ingestion) of particles or by
f-MLP occurs via intermediation of secondary
messengers. PMA is a direct PKC activator. If
inhibition of the response to all these factors
occurs in parallel (Figs. 2 and 3), then it is
conceivable that this inhibition is not related to
phagocytosis per se, nor to the role of the
secondary messengers, but rather to the
inhibition of the axis PKC—NAD(P)H-oxidase—
HMS.
indicate the presence of immune-inhibiting compounds in perito-
neal effluent [46, The factors identified by the latter authors
were, however, peptides in the middle molecular weight range
(28,000 to 9,500 Daltons), markedly higher than the putative
molecular weights considered in this study.
A first zone of inhibition is observed in hydrophilic fraction 2.
NaCl and glucose are known to elute in this fraction, and are
conceivably reponsible for a substantial part of the impressive
decreased response seen in the presence of this fraction. A similar
depressive effect was seen in fraction 2 of uremic ultrafiltrate of
hemodialyzed patients, where it was demonstrated that this effect
persisted after desalting [25].
For a second series of factors significant inhibition is observed
in fractions 7 and 11 to 13, with a nadir in the response for
fractions 7 and 12. These data conform to what has been observed
for uremic ultrafiltrate [25]. The solutes eluting here can be
considered to be partially hydrophobic and protein-bound [28].
We recently identified two hydrophobic compounds inhibiting the
response to phagocytosis as p-cresol and phenol [48]. With the
same HPLC procedure as was used in this study, phenol and
p-cresol elute in fractions 9 and 12, respectively [481. Although
both solutes are characterized by substantial protein binding, their
presence in peritoneal effluent should be considered, as PD fluid
removes and contains protein as well as protein bound com-
pounds [47, 49]
Peritoneal dialysis has been demonstrated to decrease blood
p-cresol [50]. In a recent study, it was demonstrated that p-cresol
depresses various aspects of phagocytic function [481 in concen-
trations currently found in end-stage renal disease [51]. The
present results indicate that free (non-protein bound) p-cresol is
present in the same concentrations in the CAPD effluent as in
uremic serum. Together these data suggest that (one of) the
inhibitory compound(s) in F12 may be p-cresol; it cannot, how-
ever, be excluded that one or several other, possibly even stronger
inhibitors with similar characteristics also play a role. Remarkably,
enough free p-cresol (the toxic fraction) was similar in serum and
PD effluent, in spite of much lower total concentrations in the
effluent. Effluent also contained markedly less protein.
Inhibition may be related to infection, as chemiluminescent
response was markedly lower in 6 patients who developed peri-
tonitis (Fig. 7). In other studies the degree of leukocyte and
opsonization disturbances was also related to recent infection [40,
43, 52, 53]. It is admitted that this observation needs to be
confirmed in controlled studies using larger groups of patients.
In addition, the question arises of whether the blunted GC
response in the presence of PD effluent remains prevalent in the
presence of active peritonitis, since during acute peritonitis vari-
ous proinflammatory molecules may be released that stimulate
GC activity. This might normalize the response even in the
presence of inhibitory factors. Our data obtained with infected
and noninfected effluent suggest, however, that a suppressed
response remains present in the effluent obtained during perito-
nitis, in spite of a limited correction of the defect observed in
"normal" uninfected effluent.
It is conceivable that the accumulation of solutes with a
suppressive effect on phagocytic cells will be progressive during
the dwell time, so that a progressively more important inhibition
of functional capacity can be expected with time. In agreement
with this hypothesis, JOrres et al found an increasing inhibitory
capacity of spent fluids with an increasing dwell time for the
release of tumor necrosis factor-cs and interleukin-6 by peripheral
blood mononuclear cells [31]. Taking these data together, one can
speculate that the search for osmotic agents that are alternatives
for glucose and alternative buffers in fresh dialysate for lactate,
and the reduction of dwell time, should improve the immune
response in the peritoneal cavity.
Reprint requests to Raymond Vanholder, M.D., Nephrology Department,
University Hospital, De Pintelaan 185, B9000 Gent, Belgium.
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